Search Results - "Gatto, Greg"

Pharmacokinetic Modeling to Guide Preclinical Development of an Islatravir-Eluting Reservoir-Style Biodegradable Implant for Long-Acting HIV PrEP by Kinsale, Talisa S, Cottrell, Mackenzie L, Li, Linying, Brand, Rhonda, Gatto, Greg, Luecke, Ellen, Norton, Chasity, Krovi, Archana, Dumond, Julie B, Rao, Gauri, Yeshwante, Shekhar, Van Horne, Brian, Van Der Straten, Ariane, Kashuba, Angela D M, Johnson, Leah M

“…Long-acting injectable cabotegravir is more effective than daily oral PrEP at preventing HIV transmission due to improved adherence, but requires bi-monthly…”
Get full text

Functional and structural interaction of (-)-reboxetine with the human α4β2 nicotinic acetylcholine receptor by Arias, Hugo R, Fedorov, Nikolai B, Benson, Lisa C, Lippiello, Patrick M, Gatto, Greg J, Feuerbach, Dominik, Ortells, Marcelo O

“…The interaction of the selective norepinephrine reuptake inhibitor (-)-reboxetine with the human α4β2 nicotinic acetylcholine receptor (nAChR) in different…”
Get more information

Initial in vivo testing of a multitarget kinase inhibitor, regorafenib, by the Pediatric Preclinical Testing Consortium by Harrison, Douglas J., Gill, Jonathan D., Roth, Michael E., Zhang, Wendong, Teicher, Beverly, Erickson, Stephen, Gatto, Greg, Kurmasheva, Raushan T., Houghton, Peter J., Smith, Malcolm A., Kolb, Edward Anders, Gorlick, Richard

“…Background Regorafenib is a small molecule multikinase inhibitor that inhibits multiple kinases including BRAF, KIT, PDGFRB, RAF, RET, and VEGFR1‐3. Procedures…”
Get full text

TC-2403-12. A NOVEL NICOTINIC AGONIST FOR THE TREATMENT OF ULCERATIVE COLITIS: 836 by Koumenis, Iphigenia L., Gatto, Greg, Greinwald, Roland, Tauschel, Horst-Dietmar, Traina, Vince, Veysoglu, Tarik, Bencherif, Merouane, Dunbar, Geoffrey, Winston-Salem, Targacept

Get full text